Clinical Trials Browser

Phase 4 × Non-Squamous Non-Small Cell Lung Cancer × Erlotinib Hydrochloride × Clear all

NCT01066884 2016-08-24

A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer

Phase 4 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01609543 2016-02-01

A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations

Phase 4 Completed

62 enrolled 8 charts

Non-Squamous Non-Small Cell Lung Cancer